The treatment of the HIV-positive man in China fell short of eliminating the disease, but the fact that he is well after 19 months supports ideas that gene-editing seems safe and holds promise, according to the report in the New England Journal Of Medicine. "It's not a home run at this point, but getting to first base is really critical for this technology," says Carl June , a professor in immunotherapy at the University of Pennsylvania.

from Kaiser Health News https://ift.tt/32IeRUF

Related Posts:

0 comments:

Post a Comment

Popular Posts